Vital Signsby BridgeheadAll voices

01  Voice · Academic · Rare diseases

Victor Sung: no photograph is held, so the academic plate is shown instead.
Academic

Victor Sung

MD, professor of neurology at the University of Alabama at Birmingham

Press citations per month · linked articles
1
0
Oct 2026Nov 2026to date
1

press citation on 1 topic since 6 Oct 2026 · last quoted 6 Oct 2026

02  Quoted on · 1 of 29 topics

Open the topic

Victor Sung: key facts

Kind of voice
Academic
Role
MD, professor of neurology at the University of Alabama at Birmingham
Quoted on
Rare diseases
Tracked press citations
1
Most recently quoted
6 Oct 2026

04  The signal · where Victor Sung sits on rare diseases

Ranked 31= of 100 voices quoted in the press on rare diseases, level with 69 others on 1 citation.

Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.

  1. 1Giles LomaxSector leaderChief Executive Officer, Spinal Muscular Atrophy UK (SMA UK)5
  2. 2=David Weitz portraitDavid WeitzAcademicMallinckrodt Professor of Physics and of Applied Physics; Professor of Systems Biology, Harvard University (John A. Paulson School of Engineering and Applied Sciences)4
  3. 2=Tuomas Knowles portraitTuomas KnowlesAcademic1920 Professor of Physical Chemistry, University of Cambridge4
  4. 31=Jennifer AndrewsClinicianPediatric hematologist and medical director of the blood bank at Vanderbilt University Medical Center1
  5. 31=Roozbeh GhaffariClinicianDr; CEO and co-founder, Epicore Biosystems1
  6. 31=Victor SungAcademicMD, professor of neurology at the University of Alabama at Birmingham1
  7. 31=Tracey GilliesClinicianDr, Medical Director, NHS Lothian1
  8. 31=Anna GrekaClinicianHarvard professor and physician at Mass General Brigham1

Showing the leaders and the ranks around 31=, of 100 voices · See every voice on the topic →

05  On the record · press

What Victor Sung has said

By outlet · linked articles
  • huntingtonsdiseasenews.com1

Where Victor Sung has been quoted

  1. 01Gene therapy tied to slower functional decline in Huntington’s at 4 yearshuntingtonsdiseasenews.com · 6 Oct 2026

Verbatim

“What I find particularly notable in the expanded data is the consistently meaningful treatment effect at 36 months [three years], and the apparent stability of the functional capacity benefit through Month 48.”
MD, professor of neurology at the University of Alabama at Birmingham · Rare diseases · huntingtonsdiseasenews.com · 6 Oct 2026 · Read the article

Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 10 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.